Health ❯ Clinical Research

Drug Trials

Patient Outcomes Animal Studies Mouse Models Participant Enrollment Omalizumab Drug Trials Anti-Amyloid Therapies Pipeline Development Cannabis Studies Antibiotic Efficacy Phase 3 Trials

Pfizer’s Oral Drug Shows Strong Phase 3 Results in Nonsegmental Vitiligo

The company says the medicine delivered meaningful facial and total-body repigmentation and will pursue regulatory approval for adult patients.

argenx Posts $1.52 Billion Quarter as VYVGART Readouts Loom

UK Secures Favipiravir From Japan for Cruise-Linked Hantavirus Outbreak

Biogen, Dayra Launch $50 Million Pact to Develop Oral Macrocyclic Peptides for Immunology

Roche Says Breast Cancer Pill Cuts Recurrence in Phase 3 Adjuvant Trial

Health Canada Conditionally Authorizes First Alzheimer’s Drug to Slow Early Decline

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

FDA Approves Leucovorin for Cerebral Folate Deficiency as White House Rolls Out Autism Plan

Bristol Myers’ Iberdomide Combo Hits MRD Goal in Phase 3 Myeloma Study

Semaglutide Curbs Cocaine Use and Relapse-Seeking in Rats, Peer-Reviewed Study Finds

Experimental ODN-Derived Drug Curbs Appetite Without Nausea

Experimental Drug SANA Boosts Fat Thermogenesis to Promote Weight Loss Ahead of Phase 2 Trials

UCLA Study Finds Antidepressants Boost Immune Response Against Cancer

Debate Grows Over Proposed Polypill for Preventing Heart Disease in Over-50s